EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Acute and Chronic Exposure to Linagliptin, a Selective Inhibitor of Dipeptidyl Peptidase-4 (DPP-4), Has an Effect on Dopamine, Serotonin and Noradrenaline Level in the Striatum and Hippocampus of Rats

Małgorzata Łupina iD, Agnieszka Wąsik, Irena Baranowska-Bosiacka iD, Maciej Tarnowski iD, Tymoteusz Słowik, Piotr Listos, Jolanta Kotlińska iD, Danuta Kosik-Bogacka iD, Izabela Gutowska iD, Joanna Listos

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25053008 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Małgorzata Łupina und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental and Clinical Pharmacology, Medical University of Lublin, Jaczewskiego 8b St., 20-090 Lublin, Poland. Hauptthemen laut MEDLINE: Linagliptin, Dipeptidyl-Peptidase IV Inhibitors. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This work was supported by funds from the Medical University of Lublin, Medical University of Lublin.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Linagliptin is a selective dipeptidyl peptidase-4 (DPP-4) inhibitor that indirectly elevates the glucagon-like peptide-1 (GLP-1) level. The aim of the present study was to check whether linagliptin has an influence on neurotransmission in rat brain. Rats were acutely and chronically exposed to linagliptin (10 and 20 mg/kg, intraperitoneally (i.p.)). Twenty-four hours later, the striatum and hippocampus were selected for further studies. In neurochemical experiments, using high-performance liquid chromatography with electrochemical detection (HPLC-ED), the concentrations of three major neurotransmitters—dopamine, serotonin and noradrenaline—and their metabolites were measured. The analysis of mRNA expression of dopamine (D1 and D2), serotonin (5-HT-1 and 5-HT-2) and noradrenaline (α1 and α2a) receptors was also investigated using real-time quantitative reverse transcription polymerase chain reaction (RQ-PCR) in the same brain areas. Linagliptin has the ability to influence the dopaminergic system. In the striatum, the elevation of dopamine and its metabolites was observed after repeated administration of that linagliptin, and in the hippocampus, a reduction in dopamine metabolism was demonstrated. Acute linagliptin exposure increases the serotonin level in both areas, while after chronic linagliptin administration a tendency for the mRNA expression of serotoninergic receptors (5-HT1A and 5-HT2A) to increase was observed. A single instance of exposure to linagliptin significantly modified the noradrenaline level in the striatum and intensified noradrenaline turnover in the hippocampus. The recognition of the interactions in the brain between DPP-4 inhibitors and neurotransmitters and/or receptors is a crucial step for finding novel discoveries in the pharmacology of DPP-4 inhibitors and raises hope for further applications of DPP-4 inhibitors in clinical practices.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LinagliptinDipeptidyl-Peptidase IV InhibitorsRatsAnimalsSerotoninDopamineNorepinephrineDipeptidyl Peptidase 4HippocampusNeurotransmitter AgentsRNA, Messenger

Stichwörter der Autor:innen

dipeptidyl peptidase-4 inhibitordopamineglucagon-like peptide-1linagliptinnoradrenalineserotonin

Substanzen

LinagliptinDipeptidyl-Peptidase IV InhibitorsSerotoninDopamineNorepinephrineDipeptidyl Peptidase 4Neurotransmitter AgentsRNA, Messenger

Autor:innen und Institutionen

  • Department of Experimental and Clinical Pharmacology, Medical University of Lublin, Jaczewskiego 8b St., 20-090 Lublin, Poland.
  • Department of Neurochemistry, Maj Institute of Pharmacology PAS, Smetna St. 12, 31-343 Kraków, Poland
  • Department of Biochemistry and Medical Chemistry, Pomeranian Medical University, Powstańców Wlkp. 72 Av., 70-111 Szczecin, Poland.
  • Department of Physiology in Health Sciences, Pomeranian Medical University, Żołnierska 54, 70-210 Szczecin, Poland.
  • Experimental Medicine Center, Medical University of Lublin, Jaczewskiego 8d St., 20-090 Lublin, Poland.
  • Department of Pathological Anatomy, Faculty of Veterinary Medicine, University of Life Sciences, Głęboka 30, 20-612 Lublin, Poland.

ORCID-Profile: Małgorzata Łupina, Irena Baranowska-Bosiacka, Maciej Tarnowski, Jolanta Kotlińska, Danuta Kosik-Bogacka, Izabela Gutowska

Förderung

  • This work was supported by funds from the Medical University of Lublin
  • Medical University of Lublin

Zitieren

APA

Łupina, M., Wąsik, A., Baranowska-Bosiacka, I., Tarnowski, M., Słowik, T., Listos, P., Kotlińska, J., Kosik-Bogacka, D., Gutowska, I., & Listos, J. (2024). Acute and Chronic Exposure to Linagliptin, a Selective Inhibitor of Dipeptidyl Peptidase-4 (DPP-4), Has an Effect on Dopamine, Serotonin and Noradrenaline Level in the Striatum and Hippocampus of Rats. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25053008

Vancouver

Łupina M, Wąsik A, Baranowska-Bosiacka I, Tarnowski M, Słowik T, Listos P, et al. Acute and Chronic Exposure to Linagliptin, a Selective Inhibitor of Dipeptidyl Peptidase-4 (DPP-4), Has an Effect on Dopamine, Serotonin and Noradrenaline Level in the Striatum and Hippocampus of Rats. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25053008

BibTeX
@article{upina2024,
  author = {Łupina, Małgorzata and Wąsik, Agnieszka and Baranowska-Bosiacka, Irena and Tarnowski, Maciej and Słowik, Tymoteusz and Listos, Piotr and Kotlińska, Jolanta and Kosik-Bogacka, Danuta and Gutowska, Izabela and Listos, Joanna},
  title = {Acute and Chronic Exposure to Linagliptin, a Selective Inhibitor of Dipeptidyl Peptidase-4 (DPP-4), Has an Effect on Dopamine, Serotonin and Noradrenaline Level in the Striatum and Hippocampus of Rats},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25053008}
}
Kostenlos starten →